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Abstract:  Magneto-photo-acoustic imaging, a technique based on the 
synergy of magneto-motive ultrasound, photoacoustic and ultrasound 
imaging, is introduced. Hybrid nanoconstructs, liposomes encapsulating 
gold nanorods and iron oxide nanoparticles, were used as a dual-contrast 
agent for magneto-photo-acoustic imaging. Tissue-mimicking phantom and 
macrophage cells embedded in ex vivo  porcine tissue were used to 
demonstrate that magneto-photo-acoustic imaging is capable of visualizing 
the location of cells or tissues labeled with dual-contrast nanoparticles with 
sufficient contrast, excellent contrast resolution and high spatial resolution 
in the context of the anatomical structure of the surrounding tissues. 
Therefore, magneto-photo-acoustic imaging is capable of identifying the 
nanoparticle-labeled pathological regions from the normal tissue, providing 
a promising platform to noninvasively diagnose and characterize 
pathologies. 
©2011 Optical Society of America 
OCIS codes: (170.5120) Photoacoustic imaging; (110.7170) Ultrasound; (170.3880) Medical 
and biological imaging; (170.6960) Tomography. 
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1. Introduction 
Traditional imaging techniques such as computed tomography (CT), magnetic resonance 
imaging (MRI), and ultrasound (US) have been developed to primarily provide morphological 
information. However, noninvasive, deep penetrating in vivo imaging of functional, molecular 
and cellular events is required to provide accurate localization and characterization of 
pathologies within the anatomical content of the surrounding tissues. 
Among different imaging modalities, ultrasonography is widely used because it is a non-
ionizing, cost-effective and portable imaging modality that could obtain an anatomical map of 
the tissue with excellent spatial and temporal resolution at reasonable penetration depth [1]. 
However, the sensitivity and specificity of ultrasound imaging are limited due to insufficient 
contrast between normal and pathologically transformed tissue [2]. To address the limitations 
of ultrasound imaging, various ultrasound-based techniques such as photoacoustic (PA) 
imaging [2–8] and magneto-motive  ultrasound (MMUS) imaging [9–13] have been 
developed. 
In PA imaging at large depth (beyond the quasi-ballistic photon regime [14]), the spatial 
resolution is determined by ultrasound while the imaging contrast is determined by optical 
absorption of tissue. To enable molecular PA imaging, plasmonic nanoparticles of various 
shapes and sizes, characterized by resonance absorption in a specific wavelength range, have 
been developed and used [7,8,15–17]. In molecular contrast-enhanced PA imaging, the 
distribution of nanoparticles could be measured with high sensitivity. However, significant 
background signals from endogenous chromophores in native tissue, such as hemoglobin, can 
interfere. Therefore, tissue regions labeled with plasmonic nanoparticles may have limited 
contrast compared to background tissue. To address this limitation, spectroscopic PA imaging 
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based on the differences in optical absorption spectra [8]. However, spectroscopic PA imaging 
requires a tunable or multi-wavelength laser source that is significantly more expensive than a 
single wavelength laser. Furthermore, aggregation and random orientation of anisotropic 
nanoparticles, such as nanorods, may result in unpredictable plasmonic resonance shift as the 
nanoparticles interact with cells [18]. 
In MMUS imaging [9–13], magnetic excitation is applied to induce motion within the 
tissue labeled with magnetic nanoparticles. The ultrasound waves are used to track and image 
the magnetically induced motion within the tissue. Magneto-motive ultrasound imaging can 
identify the presence and location of magnetic nanoparticles inside tissue with excellent 
contrast because the typical magnetic susceptibility of superparamagnetic nanoparticles, such 
as iron oxide, is five orders higher than that of the native tissue. Furthermore, the 
biomechanical properties, such as stiffness, of the labeled tissue can be assessed using the 
magneto-motive displacements [9–12,19]. However, MMUS imaging exhibits limited contrast 
resolution. The magneto-motive motion is determined by the magnetic force acting on the 
nanoparticles and the mechanical properties of the labeled tissue. The magnetic nanoparticles 
inside the tissue, together with the adjacent regions of the tissue, are mechanically moved 
together under the magnetic excitation, resulting in a relatively uniform magneto-motive 
displacement inside the labeled regions. Therefore, MMUS imaging may not be able to 
differentiate the variations in distribution of nanoparticles within magnetically labeled tissue. 
To address the limitations of both PA and MMUS imaging, we introduce a hybrid imaging 
technique, magneto-photo-acoustic (MPA) imaging, to detect and characterize the tissue 
regions labeled with magneto-plasmonic nanoparticles with sufficient contrast, excellent 
contrast resolution and high spatial resolution. Magneto-photo-acoustic imaging requires dual-
contrast (magneto-plasmonic) agent exhibiting enhanced optical absorption and magnetic 
susceptibility simultaneously. In MPA imaging, the high resolution photoacoustic signals 
from tissue regions labeled with magneto-plasmonic nanoparticles are identified using the 
magneto-motive motion, allowing the signals from background tissue regions to be 
suppressed. Therefore, the photoacoustic contrast between labeled and background tissue is 
significantly improved. Furthermore, photoacoustic signal amplitude filtered by the 
magnetically induced motion is indicative of the spatial distribution of nanoparticles. Thus, 
high contrast resolution is attainable in MPA imaging. Finally, MPA imaging visualizes the 
morphological and anatomical features of tissue with spatial resolution determined by 
ultrasound imaging system. 
In this paper, MPA imaging was performed using liposomes encapsulating gold nanorods 
and iron oxide nanoparticles as a dual-contrast agent. Tissue-mimicking phantoms and 
macrophage cells embedded in ex vivo porcine tissue were used to demonstrate that MPA 
imaging can identify the location of cells or tissue labeled with dual-contrast nanoparticles in 
the context of anatomical structures of the surrounding tissues. 
2. Materials and methods 
2.1 Dual-contrast agent synthesis 
The nanoconstructs, liposomal nanoparticles [20] used as dual-contrast agent for MPA 
imaging, were synthesized by incorporating superparamagnetic magnetite nanoparticles 
(Fe3O4 NPs) (Ocean NanoTech, LLC) and custom-made plasmonic gold (Au) nanorods (NRs) 
synthesized based on a published protocol into liposomes [21]. The fabrication of liposomal 
nanoparticles is shown schematically in Fig. 1. The synthesis of the dual-contrast agent began 
with the formation of a lipid cake. A solution of 1 mL egg phosphatidylcholine (Egg-PC) and 
0.11 mL 1,2-dioleoyl-sn-glycero-3-ethylphosphocholine (DOPC) in chloroform (Avanti Polar 
Lipids, Inc.) was added to a 50 mL pear-shaped flask. Both Egg-PC and DOPC samples used 
in our experiments were 10 mg/mL. The solution was rotated at 100 rpm in room temperature 
water bath at a reduced pressure of 400 mbar in a rotary evaporator. After approximately 30 
minutes, all of the chloroform evaporated from the lipid solution, resulting in an evenly 
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flask. The flask was removed from the rotary evaporator and stored in a desiccator at reduced 
pressure overnight to ensure complete evaporation of chloroform from the lipid cake. Upon 
hydrating the lipid cake with an aqueous solution of nanoparticles, the nanoparticles would be 
trapped within the multi-lamellar liposomes (MLLs) as they spontaneously assembled. To 
ensure the liposomal nanoparticles exhibited both plasmonic and magnetic properties, the 
lipid cake was hydrated with a 1X phosphate buffered saline (PBS) solution containing 15 nm 
Fe3O4  NPs and ~10 nm by ~50 nm Au NRs. The lipid cake was hydrated with the 
nanoparticles solution for 30 minutes at atmospheric pressure at 75 rpm and 45°C. The MLLs 
containing Fe3O4 NPs and Au NRs underwent five freeze-thaw cycles (FTCs) to produce 
single-lamellar liposomes (SLLs). In the freeze-thaw cycles, the liposomal solution was 
frozen in dry ice for approximately 15 minutes and immediately thawed in a 45°C water bath. 
The FTCs fracture the outer lipid bilayers of the MLLs, leaving the liposomal nanoparticles 
with a single lipid bilayer. The diameters of the SLLs obtained after the FTCs were 
substantially varied due to the spontaneous formation of the MLLs upon hydration of the lipid 
cake. The SLLs were extruded through a 200 nm filter to obtain nanoparticles with mean 
diameter of 200 nm. In the prepared solution of dual-contrast liposomal nanoparticles, the 
concentration of Au NRs was approximately 28 nM (1.18 mg/mL), while the concentration of 
Fe3O4 NPs was approximately 250 nM (1 mg/mL). In each liposomal nanoparticle, there were 
2 ± 1Au NRs and 35 ± 18 Fe3O4 NPs (mean/standard deviation). Dynamic light scattering 
(DLS) analysis indicated that the empty liposomes prepared using the same protocol had an 
average diameter of 213.0 nm and a polydispersity index of 0.205. 
Lipid cake N nm MLLs 200 nm SLLs
Fe3O4 Au NRs
200 nm 
extrusion filter
 
Fig. 1. Schematic diagram for preparation of liposomes encapsulating gold nanorods (Au NRs) 
and iron oxide nanoparticles (Fe3O4 NPs). 
The liposomal nanoparticles were characterized with transmission electron microscopy 
(TEM) and UV-vis spectroscopy. The TEM image of liposomal nanoparticle, presented in 
Fig. 2(a), shows that Fe3O4  NPs and Au NRs were successfully packaged within the 
liposomes. The UV-vis spectra of 1X PBS solution containing Fe3O4 NPs and Au NRs for 
hydrating the lipid cake (dashed line) and the final liposomal nanoparticles (solid line) are 
shown in Fig. 2(b). The PBS solution containing both Fe3O4 NPs and Au NRs exhibits a 
strong plasmonic resonance at 798 nm. After hydrating lipid cake with the PBS solution, the 
dual-contrast liposomal nanoparticles exhibit a broader plasmonic resonance at 815 nm. The 
red-shift and broader range of resonance absorption of the liposomal nanoparticles compared 
to the PBS solution reflects a change in the local dielectric field resulting from the interaction 
of Fe3O4 NPs and Au NRs when they were encapsulated in the liposomes [22]. 
2.2 Phantom construction 
To initially demonstrate the feasibility of MPA imaging, the experiments were performed 
using the tissue-mimicking phantom with six inclusions. The background of the tissue-
mimicking phantom was prepared by mixing 2 wt% gelatins with 0.002 wt% graphite to 
represent the endogenous chromophores in native tissue. The inclusions were prepared by 
mixing 10 wt% gelatins with different types of nanoparticles at different concentrations. 
Specifically, the first inclusion contained gelatin only and was used as control (inclusion I). 
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Fig. 2. (a) The TEM image of liposomes encapsulating Au NRs and Fe3O4  NPs. (b) The 
extinction spectra of liposomal nanoparticles (solid line) and PBS solution (dashed line) 
containing Au NRs and Fe3O4 NPs. 
The other inclusions contained 0.70 mg/mL Au NRs (inclusion II), 0.60 mg/mL Fe3O4 
NPs(inclusion III), high concentration (0.70 mg/mL Au and 0.60 mg/mL Fe3O4) of dual-
contrast liposomal nanoparticles (inclusion IV), and low concentration (0.47 mg/mL Au and 
0.40 mg/mL Fe3O4) of dual-contrast liposomal nanoparticles (inclusion V). Finally, a 
composite inclusion (inclusion VI) was made consisting of adjacent regions with high and low 
concentrations of liposomal nanoparticles. The concentrations of liposomal nanoparticles in 
these regions of inclusion VI were the same as that in inclusions IV and V, respectively. In 
other words, inclusion VI was equivalent to inclusions IV and V placed together and 
interconnected.  In  addition,  0.1  wt%  and  0.2  wt%  of  30  μm  silica  particles,  acting  as 
ultrasound scatters, were added to the background material and inclusions, respectively. 
To further demonstrate the MPA imaging, excised porcine longissimus dorsi muscle tissue 
sample injected with macrophages which were labeled with Fe3O4  NPs and Au NRs and 
suspended in 12% gelatin solution, was used. To prepare the sample, the J774A.1 
macrophages were cultured in Dulbecco's Modified Eagle Media (DMEM), and supplemented 
with 5% FBS at 37°C in 5% CO2. To load cells with the dual-contrast agent (Fe3O4 NPs and 
Au NRs), macrophages were incubated with a 3 mL suspension of sterilized 0.1 mg/mL Au 
NRs and 0.3 mg/mL Fe3O4 NPs for 24 hours. The cells and particles were centrifuged at 110 g 
for 3 min, and unbound particles in the supernatant were discarded. The darkfield images of 
native cells and the labeled cells are shown in Fig. 3(a) and Fig. 3(b), respectively. The bright 
color of the labeled cells comes from the internalized nanoparticles. The extinction spectra of 
native macrophages and macrophages labeled with both Fe3O4 NPs and Au NRs are shown in 
Fig. 3(c). 
2.3 Magneto-photo-acoustic (MPA) imaging 
A block diagram of the MPA imaging system is shown in Fig. 4. Either tissue-mimicking 
phantom or tissue sample was placed in a water cuvette attached to a 3-D positioning stage. 
For PA imaging, a tunable optical parametric oscillator (OPO) pulsed laser system operating 
at an 800 nm wavelength (peak absorption of Au NRs) and pulse duration of 5 ns was used to 
irradiate the sample and to generate photoacoustic signals. The laser light was delivered from 
the top of the sample using a 1.5 mm diameter optical fiber. The photoacoustic signals were 
detected using a single element ultrasound transducer (25 MHz center frequency, 25.4 mm 
focal depth) connected to ultrasound pulser/receiver. For ultrasound imaging, the ultrasound 
pulse was transmitted 30 µs after the laser pulse to ensure that the photoacoustic transients  
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Fig. 3. Darkfield images of (a) native macrophages and (b) macrophages labeled with Au NRs 
and Fe3O4 NPs. (c) The extinction spectra of native cells (dashed line) and cells (solid line) 
labeled with Au NRs and Fe3O4 NPs. 
were completely captured, and the backscattered ultrasound echo signals were detected using 
the same ultrasound transducer. Finally, the pulsed magnetic field (8 ms pulse duration) was 
produced using a magnetic pulser connected to a solenoid with cone-shaped-tip core to focus 
the field. The magnetic field generated the magnetically-induced motion inside the tissue 
while the ultrasound pulse-echo signals were acquired at 1 kHz pulse repetition rate to track 
the magneto-motive displacement. Therefore, at each lateral  position of the ultrasound 
transducer, photoacoustic signal and a series of ultrasound pulse-echo signals before and after 
the application of magnetic field were captured. A custom-built LabVIEW application 
controlled the time sequences of pulsed laser system, ultrasound pulser/receiver, pulsed 
magnetic field generator, data acquisition unit, and motion axes for mechanical scanning 
[7,8]. The 2-D cross-sectional and spatially co-registered images were obtained by 
mechanically moving the sample in horizontal (lateral) direction. 
During the offline processing, a digital band-pass (5-45 MHz) filter was applied to 
photoacoustic and ultrasound radiofrequency signals to filter the out-of-band noise and to 
improve signal-to-noise ratio. The analytic signals were obtained by applying the Hilbert 
transform on the filtered signals. The absolute values of the photoacoustic and ultrasound 
analytic signals were spatially resolved to form PA and US images, respectively. The 
magneto-motive displacement was detected using a block-matching motion tracking algorithm 
based on 2D cross-correlation [23]. At each pixel, the displacement between reference signal 
and ultrasound pulse-echo signals collected at 1 kHz pulse repetition rate during and after the 
magnetic excitation was estimated from the position of the maximum of correlation 
coefficient  calculated  using  a  correlation  kernel  measuring  750  μm  axially  and  100  μm 
laterally. Once the temporal profile of the displacement was calculated, the maximum 
displacement at each pixel was mapped in the MMUS image. It should be noted that the 
background displacement of MMUS imaging was defined as the displacement from a 
stationary reference (e.g., bottom of the water cuvette) and was subtracted from the estimated 
displacement of the sample. To form the MPA image, the ultrasound gray-scale B-scan image 
was used as a background map. Then, using co-registered PA and MMUS images, the 
magnitude of photoacoustic signal at each pixel was multiplied by the normalized magneto-
motive ultrasound signal at the same pixel, and the resulting values were color-coded using 
logarithmic scale and displayed over the ultrasound image. 
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Fig. 4. A block diagram for the magneto-photo-acoustic (MPA) imaging system. 
3. Results and discussion 
Experiments using tissue-mimicking phantom were performed to demonstrate that MPA 
imaging is capable of detecting and identifying the regions labeled with dual-contrast 
nanoparticles with sufficient contrast and excellent contrast resolution. Figure 5(a) shows the 
B-scan ultrasound image of the tissue-mimicking phantom where six inclusions were 
embedded in the phantom are marked. One of the inclusions (inclusion I) did not contain any 
contrast agent and was used as control, while other inclusions contained different types of 
contrast agents at different concentrations. The structure of the tissue-mimicking phantom and 
the locations of the inclusions were depicted in the B-scan ultrasound image. However, the 
US image cannot differentiate the inclusions due to the insignificant ultrasound contrast from 
the nanoparticles. In contrast, strong photoacoustic signals were detected only from the 
inclusions containing photoacoustic contrast agent: Au NRs (inclusion II) or dual-contrast 
liposomal nanoparticles (inclusions IV, V and VI). To quantitatively investigate the contrast 
enhancement in the PA image by nanoparticles, the magnitude of the averaged photoacoustic 
signal from each marked region was calculated and displayed in Fig. 5(b). The height of each 
column represents the magnitude of the averaged photoacoustic signal from the corresponding 
region, and the error bar shows the standard deviation of the photoacoustic signal. The PA 
image of the tissue-mimicking phantom is also shown in Fig. 5(b). 
As evident from Fig. 5(b), the inclusions that contain either Au NRs or liposomal 
nanoparticles have elevated optical absorption compared to the background. In addition, PA 
imaging is sensitive to the spatial variations of optical absorption; the differences in 
photoacoustic signals from the inclusions were consistent  with the concentrations of the 
plasmonic nanoparticles. As shown in Fig. 5(b), the control inclusion (inclusion I) and the 
inclusion containing Fe3O4  NPs (inclusion II) did not generate significant photoacoustic 
signals. This was expected since light absorption at a wavelength 800 nm was insignificant. 
Inclusions II, IV and the left region of inclusion VI containing high concentration of Au NRs,  
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Fig. 5. (a) The ultrasound (US) image of the tissue-mimicking phantom with six inclusions. 
The background of the phantom was prepared by mixing gelatin with optical contrast agent to 
represent the endogenous chromophores in native tissue. The inclusions were prepared by 
mixing gelatin with different types of contrast agents at different concentrations. The first 
inclusion contained gelatin only and was used as a control (inclusion I). Other inclusions 
contained 0.70 mg/mL Au NRs (inclusion II), 0.60 mg/mL Fe3O4 NPs (inclusion III), high 
concentration (0.70 mg/mL Au and 0.60 mg/mL Fe3O4) of dual-contrast liposomal 
nanoparticles (inclusion IV), and low concentration (0.47 mg/mL Au and 0.40 mg/mL Fe3O4) 
of dual-contrast liposomal nanoparticles (inclusion V). Inclusion VI consists of two regions, 
which were equivalent to inclusions IV (left region) and V (right region) placed together and 
interconnected. (b) The magnitude of the averaged photoacoustic (PA) signal from each 
marked region in Fig. 5(a), and the PA image of the tissue-mimicking phantom. (c) The 
magneto-motive displacement of each marked region and the magneto-motive ultrasound 
(MMUS) image of the phantom. (f) Magneto-photo-acoustic (MPA) image of the tissue-
mimicking phantom. Each image covers area measuring 7.7 mm axially and 56 mm laterally. 
either isolated or encapsulated in liposomal nanoparticles, generated intense photoacoustic 
signals. Inclusion IV and the right region of inclusion VI contained low concentrations of 
liposomal nanoparticles, which encapsulated fewer Au NRs, therefore produced weaker 
photoacoustic signals. Overall, the magnitude of photoacoustic signal is representative of 
concentration of plasmonic nanoparticles. However, there are also noticeable photoacoustic 
signals generated from the background material (mimicking endogenous chromophores in the 
native tissue). These background signals reduce the contrast of PA imaging and ability to 
identify the regions labeled by nanoparticles. 
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magnetic nanoparticles with high contrast because the tissues have fairly low magnetic 
susceptibility compared to magnetic nanoparticles. The graph shown in Fig. 5(c) indicates the 
mean value and standard deviation of magneto-motive displacement measured within a 
rectangular window measuring 1.5 mm axially and laterally located at the center of each 
inclusion. The detected displacement in the background of the tissue-mimicking phantom was 
around 5 μm. The control inclusion (inclusion I) and the inclusion with Au NRs (inclusion II) 
exhibit almost no contrast in the MMUS image. Other inclusions containing Fe3O4 NPs or 
liposomal nanoparticles could be easily identified in the MMUS image. The largest magneto-
motive displacement (around 35 μm) was measured in the inclusion containing Fe3O4 NPs 
(inclusion III). Although inclusion IV contained the same concentration of Fe3O4  NPs 
encapsulated in liposomes, the detected displacement from inclusion IV was around 30 μm. 
The slight difference in the displacements between inclusion III and IV is likely due to 
additional weight of Au NRs in liposomal nanoparticles. Comparing the displacements 
detected from inclusions IV and V, which contained different concentrations of liposomal 
nanoparticles, it is clear that as the concentration of the magnetic nanoparticles decreases, the 
induced displacement decreases accordingly. However, the map of magneto-motive 
displacement in inclusion VI was approximately uniform although the inclusion contained two 
regions (left and right) with different concentrations of liposomal nanoparticles. In fact the 
difference of concentrations of nanoparticles between left and right regions in inclusion VI 
was exactly the same as the difference between inclusion IV and inclusion V. Therefore, the 
MMUS imaging has limited ability to distinguish the regions containing spatially varying 
concentrations of magnetic nanoparticles if the regions are close to each other and 
mechanically connected. Thus, MMUS imaging exhibits low contrast resolution within the 
tissue with sub-regions containing different concentration of nanoparticles. However, the 
MPA image of the tissue-mimicking phantom shown in Fig. 5(d) retains the best properties of 
each subsequent imaging technique. Specifically, the MPA image identifies the inclusions 
containing dual-contrast agent, liposomes encapsulating Fe3O4 NPs and Au NRs. Indeed, only 
the inclusions containing dual-contrast liposomal nanoparticles (inclusions IV, V and VI) 
were color-coded in the MPA image, and the signals from other inclusions and background 
were highly reduced. Furthermore, the regions with different concentrations of dual-contrast 
nanoparticles could be clearly distinguished using MPA imaging. Therefore, MPA imaging 
was capable of accurate representation of the tissue labeled with dual-contrast agents in the 
phantom. 
The  ex-vivo  experiment with macrophages was designed to test the ability of MPA 
imaging to detect cells labeled with nanoparticles within the tissue. The US, PA, MMUS and 
MPA images of a tissue sample injected with nanoparticle-labeled macrophages are shown in 
Fig. 6. The B-scan ultrasound image shown in Fig. 6(a) visualizes the cross-sectional view of 
the tissue sample with injected macrophages. However, the macrophages cannot be easily 
identified because ultrasound backscattering from macrophages is similar to that of the 
background tissue, and the nanoparticles internalized by the cells do not provide significant 
contrast in ultrasound images. The PA image shown in Fig. 6(b) could visualize the labeled 
cells in the tissue based on the optical absorption from the nanoparticles. But noticeable 
photoacoustic signals were also detected from background tissue, especially in the upper 
boundary of the tissue, because of the strong light absorption by endogenous chromophores 
within the tissue. Therefore, the contrast in the PA image is reduced. The MMUS image 
shown in Fig. 6(c) identifies the presence of nanoparticles inside the tissue and suggests the 
location of nanoparticle-labeled macrophages with sufficiently high contrast. Indeed, the 
magneto-motive displacement in the region containing macrophages was around 100 µm, 
while the displacement from the background tissue was around 8 µm. Finally, the MPA 
image, obtained from the co-registered PA, MMUS, and US images and displayed in Fig. 
6(d), identified the nanoparticle-labeled macrophages with sufficient contrast, excellent 
contrast resolution and high spatial resolution with the anatomic features of the imaged tissue. 
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Fig. 6. (a) US image, (b) PA image, (c) MMUS image and (d) MPA image of ex vivo tissue 
sample injected with macrophage labeled with Au NRs and Fe3O4 NPs. The images cover area 
measuring 5.4 mm axially by 4.5 mm laterally. 
Our results indicate the feasibility of MPA imaging to visualize the presence and location 
of nanoparticles inside tissue/cells with the spatial resolution of ultrasound imaging and 
enhanced contrast based on both the optical absorption and the magnetic susceptibility of the 
dual-contrast agent. Magneto-photo-acoustic images of the tissue-mimicking phantom and 
tissue sample were obtained by combining the co-registered US, PA and MMUS images. In 
the MPA image, only the signals from cells or tissue labeled with dual-contrast agent were 
selected and displayed over the anatomical content of the tissue, while the background or 
nonspecific signals were significantly suppressed. Therefore, MPA imaging enhances the 
contrast between the nanoparticle-labeled cells or tissues and the surrounding tissue. In the 
desired region labeled with dual-contrast nanoparticles, the MPA image provides high 
contrast resolution utilizing the sensitivity of photoacoustic signals to the variation of optical 
absorption caused by different concentration of nanoparticles. In addition, MPA imaging 
retains high spatial resolution determined by the ultrasound imaging system. Finally, the 
alignment of the data sets from different modalities in MPA imaging is simple and accurate 
because of the shared detection system. Therefore, the MPA image allows the improved 
spatial localization of the desired cells or tissue regions labeled with magneto-plasmonic 
nanoparticles with high sensitivity. 
The liposomes containing Au NRs and Fe3O4 NPs were used as the dual-contrast agent in 
our experiments. The nanoconstructs were designed to exhibit both plasmonic resonance in 
near–infrared (NIR) spectral region and high magnetic susceptibility. The liposomal 
nanoparticles allowed flexibility in the loading ratio of Au NRs to Fe3O4 NPs. In addition to 
liposomal nanoparticles, various other hybrid nanoparticles could also be used as the contrast 
agent for MPA imaging [22,24,25]. Furthermore, new particles optimized for MPA imaging 
can be designed [20]. 
Magneto-photo-acoustic imaging is a promising tool for various biomedical applications. 
For instance, MPA imaging can assess mechanical and optical properties of soft tissue. 
Photoacoustic imaging can map optical absorption property of the tissue [3–8], while the 
displacements measured in MMUS imaging can indicate the elasticity and viscosity of the soft 
tissue [12,13,19]. Since there is significant correlation between diseases and local changes of 
soft tissue properties detected using MPA imaging, the MPA imaging technique has potential 
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can be used to guide and assess photothermal therapy by using the dual-contrast agent [13]. 
Because of the presence of the magnetic component, the dual-contrast nanoparticles can be 
actively accumulated into the desired region using an external magnetic field. Based on the 
optical absorption property, the nanoparticles can lead to localized thermal damage by 
absorbing the radiant energy from the laser. The efficient targeting of nanoparticles through 
the magnetic field increases the effectiveness of the treatment and reduces the required dosage 
of photoabsorbers, thereby reducing the side effects associated with general systematic 
administration of nanoparticles. In addition, the dynamic MPA imaging of the targeted tissue 
can indicate the presence of the photo absorbers and assess the therapeutic outcome. The 
temperature maps measured with PA imaging [26] and the tissue elasticity measured with 
MMUS imaging [12,13,19] are important parameters expected to change significantly during 
the photothermal therapy. 
Finally, molecular MPA imaging could be realized by functionalizing the surfaces of the 
dual-contrast nanoconstructs, allowing for improved spatial localization of the targeted cells 
in the context of the anatomic map of the tissue. Since the molecular localization of 
nanoparticles could be indicative of specific physiology, MPA imaging might provide a 
promising platform to noninvasively diagnose and characterize pathologies. 
4. Conclusion 
In conclusion, MPA imaging using the dual-contrast agent characterized by elevated optical 
absorption and magnetic susceptibility was developed. The liposomes containing Au NRs and 
Fe3O4 NPs were designed and used as the dual-contrast agent for MPA imaging. We have 
investigated multi-modal MPA imaging to image a tissue-mimicking phantom and tissue 
sample injected with cells labeled by a dual-contrast agent, and obtained the MPA images by 
co-registering B-mode US, PA and MMUS images from the same cross-section of the 
samples. The MPA image could clearly define the localization of the nanoparticle-labeled 
cells or tissue with enhanced contrast, excellent contrast resolution and high spatial resolution 
in the context of anatomical landmarks of the surrounding tissues. The precise morphological 
information from MPA imaging provides an important basis for diagnosis, characterization 
and treatment of pathologies. 
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